Lin Z et al. revealed that metabolic reprogramming has been observed in NSCLC through RNA modifications of cytochrome c oxidase subunit 6B2 (COX6B2) via the IGF2BP3-COX6B2 axis, which could alter OXPHOS [37]. The gene discussed is COX6B2; the disease is non-small cell lung carcinoma.